This study demonstrated DOT1L inhibitor SGC0946 combined with EZH2 inhibitor GSK343 had high selectivity against NB cells through induction of an ATF4‐mediated endoplasmic reticulum (ER) stress response. The gene discussed is DOT1L; the disease is neuroblastoma.